Enzo Biochem, Inc. (ENZ)
NYSE: ENZ · IEX Real-Time Price · USD
1.150
+0.010 (0.88%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Enzo Biochem Income Statement
Financials in millions USD. Fiscal year is August - July.
Millions USD. Fiscal year is Aug - Jul.
Year Ending | TTM | Jul 31, 2023 | Jul 31, 2022 | Jul 31, 2021 | Jul 31, 2020 | Jul 31, 2019 | 2018 - 2013 |
|---|---|---|---|---|---|---|---|
| Revenue | 33.34 | 31.06 | 32.64 | 117.73 | 76.02 | 81.17 | Upgrade
|
| Revenue Growth (YoY) | - | -4.85% | -72.27% | 54.87% | -6.34% | -19.64% | Upgrade
|
| Cost of Revenue | 18.78 | 19.5 | 19.21 | 64.15 | 52.25 | 57.92 | Upgrade
|
| Gross Profit | 14.56 | 11.57 | 13.43 | 53.58 | 23.77 | 23.25 | Upgrade
|
| Selling, General & Admin | 28.24 | 32.4 | 28.52 | 49.63 | 49.69 | 47.27 | Upgrade
|
| Research & Development | 3.23 | 3.9 | 2.44 | 3.25 | 4.45 | 3.18 | Upgrade
|
| Operating Expenses | 31.47 | 36.3 | 30.96 | 52.89 | 54.14 | 50.44 | Upgrade
|
| Operating Income | -16.91 | -24.74 | -17.53 | 0.69 | -30.37 | -27.19 | Upgrade
|
| Interest Expense | -1.12 | -1.12 | - | - | - | - | Upgrade
|
| Interest & Investment Income | 2.5 | - | 0.18 | 0.01 | 0.45 | 1.06 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.58 | 1.28 | -2.22 | 0.27 | 0.91 | -0.68 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.43 | -0.44 | 0.02 | -0.01 | 0.49 | 0.38 | Upgrade
|
| EBT Excluding Unusual Items | -17.55 | -25.02 | -19.56 | 0.96 | -28.52 | -26.44 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -1.28 | -0.08 | - | - | Upgrade
|
| Legal Settlements | - | - | 0.5 | - | - | 28.93 | Upgrade
|
| Other Unusual Items | - | - | - | 7 | - | - | Upgrade
|
| Pretax Income | -17.55 | -25.02 | -20.34 | 7.88 | -28.52 | 2.49 | Upgrade
|
| Earnings From Continuing Operations | -17.55 | -25.02 | -20.34 | 7.88 | -28.52 | 2.49 | Upgrade
|
| Earnings From Discontinued Operations | 62.28 | 45.31 | 2.08 | - | - | - | Upgrade
|
| Net Income | 44.73 | 20.29 | -18.26 | 7.88 | -28.52 | 2.49 | Upgrade
|
| Net Income to Common | 44.73 | 20.29 | -18.26 | 7.88 | -28.52 | 2.49 | Upgrade
|
| Shares Outstanding (Basic) | 50 | 49 | 49 | 48 | 48 | 47 | Upgrade
|
| Shares Outstanding (Diluted) | 50 | 49 | 49 | 48 | 48 | 47 | Upgrade
|
| Shares Change (YoY) | 3.14% | 1.16% | 0.56% | 1.32% | 0.46% | 1.07% | Upgrade
|
| EPS (Basic) | 0.89 | 0.41 | -0.38 | 0.16 | -0.60 | 0.05 | Upgrade
|
| EPS (Diluted) | 0.89 | 0.41 | -0.38 | 0.16 | -0.60 | 0.05 | Upgrade
|
| Free Cash Flow | -43.2 | -39.74 | -20.06 | -4.05 | -19.35 | -3.32 | Upgrade
|
| Free Cash Flow Per Share | -0.86 | -0.81 | -0.41 | -0.08 | -0.41 | -0.07 | Upgrade
|
| Gross Margin | 43.66% | 37.24% | 41.14% | 45.51% | 31.27% | 28.64% | Upgrade
|
| Operating Margin | -50.72% | -79.64% | -53.69% | 0.59% | -39.95% | -33.50% | Upgrade
|
| Profit Margin | 134.17% | 65.32% | -55.94% | 6.69% | -37.52% | 3.07% | Upgrade
|
| Free Cash Flow Margin | -129.57% | -127.93% | -61.46% | -3.44% | -25.45% | -4.09% | Upgrade
|
| EBITDA | -15.43 | -22.05 | -14.7 | 3.35 | -27.59 | -24.16 | Upgrade
|
| EBITDA Margin | -46.28% | -71.00% | -45.03% | 2.84% | -36.29% | -29.76% | Upgrade
|
| D&A For EBITDA | 1.48 | 2.68 | 2.83 | 2.65 | 2.78 | 3.04 | Upgrade
|
| EBIT | -16.91 | -24.74 | -17.53 | 0.69 | -30.37 | -27.19 | Upgrade
|
| EBIT Margin | -50.72% | -79.64% | -53.69% | 0.59% | -39.95% | -33.50% | Upgrade
|
| Advertising Expenses | - | 0.35 | 0.58 | 0.4 | 0.44 | 0.37 | Upgrade
|
Source: S&P Capital IQ. Standard template.